Nurse Practitioner in Bridgeview, IL Accepting Medicare

3 Nurse Practitioner nurses found. Showing 1 - 3

Mohammad Khader, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 7124 W 83rd St Unit C, Bridgeview, IL 60455 Phone: 708-424-0909    Fax: 708-424-1715

Mr. Sager Abu Inseir, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 8338 S 77th Ct, Bridgeview, IL 60455 Phone: 773-520-2090

Leonor Elizabeth Delgadillo, FNP-BC Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 7020 W 79th St, Bridgeview, IL 60455 Phone: 708-599-8200    Fax: 708-599-8306

News Archive

Study investigates efficacy of blood analysis with cognitive testing for early diagnosis of AD

One key problem with treating people with Alzheimer's disease (AD) is the fact that it is often very difficult to detect the disease when it is in the early stages of progression. A team of researchers from the University of the West of England are about to embark on a preliminary study to investigate the efficacy of combining biomarkers in blood with cognitive testing as a way of screening for AD early on so that appropriate treatments can be offered to patients sooner.

QualityMetric announces new tool to measure pain accurately

According to the National Centers for Health Statistics, 76.2 million Americans report problems with chronic pain; more than diabetes, heart disease, and cancer combined. The same report notes that the annual cost of chronic pain in the United States, including healthcare expenses, lost income, and productivity, is estimated to be $100 billion.

Tibial artery calcification predicts foot ulceration

Tibial artery calcification is a significant risk factor for foot ulcers in patients with Type 2 diabetes, research suggests.

New guidance on selection and evaluation of wearable devices for use in regulatory clinical trials

Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new guidance regarding the selection and evaluation of wearable devices for use in regulatory trials and to support labeling claims.

Key mechanism for systemic delivery of RNAi therapeutics using LNPs discovered

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has discovered a key mechanism related to the systemic delivery of RNAi therapeutics using lipid nanoparticles (LNPs). The new pre-clinical research was presented at the "Advances in Biopharmaceuticals" Keystone Symposium held January 8-13, 2010 in Midway, Utah, and was performed in collaboration with scientists at the Max Planck Institute of Molecular Cell Biology and Genetics.

Read more Medical News

› Verified 1 days ago